Genprex, Inc. (GNPX)
1.75
-0.01
(-0.57%)
USD |
NASDAQ |
Dec 31, 11:57
Genprex EPS Diluted (Quarterly): -4.996 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GlucoTrack, Inc. | -4.638 |
| Arvinas, Inc. | -0.4795 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.799M |
| Total Expenses (Quarterly) | 3.799M |
| Enterprise Value | 0.6643M |
| Earnings Yield | -2.00K% |
| Normalized Earnings Yield | -1996.49 |